Literature DB >> 19490820

Pathophysiology of prediabetes.

Muhammad A Abdul-Ghani1, Ralph A DeFronzo.   

Abstract

The term prediabetes refers to subjects with impaired fasting glucose and/or impaired glucose tolerance who are at increased risk for type 2 diabetes mellitus. Although both types of patients are at increased risk for developing type 2 diabetes mellitus and cardiovascular disease, they manifest distinct metabolic abnormalities. In this article, we summarize the metabolic abnormalities that characterize each state and the contribution of these metabolic abnormalities to the increased risk of diabetes and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490820     DOI: 10.1007/s11892-009-0032-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  60 in total

1.  Who are more insulin resistant, people with IFG or people with IGT?

Authors:  T Wasada; H Kuroki; K Katsumori; H Arii; A Sato; K Aoki
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

2.  Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Authors:  Christian Meyer; Walkyria Pimenta; Hans J Woerle; Timon Van Haeften; Ervin Szoke; Asimina Mitrakou; John Gerich
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  Disturbances in beta-cell function in impaired fasting glycemia.

Authors:  Timon W van Haeften; Walkyria Pimenta; Asimina Mitrakou; Mary Korytkowski; Trond Jenssen; Hannele Yki-Jarvinen; John E Gerich
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

4.  Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

Authors:  M I Harris; R C Eastman; C C Cowie; K M Flegal; M S Eberhardt
Journal:  Diabetes Care       Date:  1997-12       Impact factor: 19.112

5.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

Review 6.  Dysfunctional fat cells, lipotoxicity and type 2 diabetes.

Authors:  R A DeFronzo
Journal:  Int J Clin Pract Suppl       Date:  2004-10

7.  The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.

Authors:  David W Dunstan; Paul Z Zimmet; Timothy A Welborn; Maximilian P De Courten; Adrian J Cameron; Richard A Sicree; Terry Dwyer; Stephen Colagiuri; Damien Jolley; Matthew Knuiman; Robert Atkins; Jonathan E Shaw
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

8.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Authors:  Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

9.  Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.

Authors:  G T Ko; J C Chan; J Woo; C S Cockram
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

Review 10.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

View more
  60 in total

1.  [Screening and prevention of diabetes].

Authors:  P E H Schwarz
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

Review 2.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

3.  What we have learnt about PIKE from the knockout mice.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  Int J Biochem Mol Biol       Date:  2011-06-07

Review 4.  Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism.

Authors:  Steven K Malin; Zhenqi Liu; Eugene J Barrett; Arthur Weltman
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

5.  Early metabolic defects in Arab subjects with strong family history of Type 2 diabetes.

Authors:  A Shalata; W Jazmawi; O Aslan; K Badarni; K Dabbah; S Sawaed; O Cohen Castel; Z U Borochowitz; K Karkabi; R Defronzo; M Abdul-Ghani
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

6.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Authors:  Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

7.  A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control.

Authors:  Scott B Widenmaier; Su-Jin Kim; Gary K Yang; Thomas De Los Reyes; Cuilan Nian; Ali Asadi; Yutaka Seino; Timothy J Kieffer; Yin Nam Kwok; Christopher H S McIntosh
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

8.  alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.

Authors:  Walter E Gall; Kirk Beebe; Kay A Lawton; Klaus-Peter Adam; Matthew W Mitchell; Pamela J Nakhle; John A Ryals; Michael V Milburn; Monica Nannipieri; Stefania Camastra; Andrea Natali; Ele Ferrannini
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

9.  Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.

Authors:  Anke Tönjes; Mathias Fasshauer; Jürgen Kratzsch; Michael Stumvoll; Matthias Blüher
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

10.  The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.

Authors:  Mustafa Kanat; Diedre Winnier; Luke Norton; Nazik Arar; Chris Jenkinson; Ralph A Defronzo; Muhammad A Abdul-Ghani
Journal:  Diabetes Care       Date:  2011-02-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.